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Progress in tissue engineering is now impacting beyond the field of regen-
erative medicine. Engineered tissues are now used as tools to evaluate the
toxicity of compounds or even to enable the modelling of disease. While
many of the materials that are used to facilitate tissue growth are designed
to enable cell attachment, many researchers consider that the contraction
and modification of these matrices by attached cells is not desirable and
take measures to prevent this from occurring. Where substantial alignment
of the molecules within tissues, however, is a feature of structure the process
of contraction can be exploited to guide new matrix deposition. In this
paper, we will demonstrate how we have used the cell contraction process
to generate tissues with high levels of organization. The tissues that have
been grown in the laboratory have been characterized using a suite of
analytical techniques to demonstrate significant levels of matrix organization
and mechanical behaviour analogous to natural tissues. This paper provides
an overview of research that has been undertaken to determine how tissues
have been grown in vitro with structuring from the molecular, right through
to the macroscopic level.
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Adhesion is important at all levels of biology and is critical to both structure
and function. At the molecular level, it is the adhesion of enzymes to their sub-
strates that facilitates many of the chemical reactions that are vital to life.
Beyond this scale, the attachment of cells to an extracellular matrix (ECM) con-
trols how cells behave and can respond to their environment [1,2]. Subsequent
levels of organization, facilitated through adhesion between molecules within
the ECM, are what enable connective tissues to perform under demanding
mechanical loads placed on them by the body [3]. This paper summarizes
the adhesions that are important at each length scale and describes how
adhesion is being exploited to regenerate tissues and recapitulate the impressive
levels of organization. The main focus of the review is on highly aligned tissues,
ligament and tendon, but the methods reported could be used to generate more
complex structure. The review is organized so that the adhesive forces impor-
tant at the ECM level, cell-matrix level and tissue level are discussed in turn.2. The extracellular matrix: molecular nature and structural
adaptation
The ECM is a three-dimensional space within an organ or tissue that surrounds
populations of cells and functions as an adhesive and supportive structure. The
ECM is formed from water, proteins, proteoglycans and glycosaminoglycans
(GAGs), each of which have important mechanical and biological roles. It is
the proportions and orientations of each of these components that determine
tissue function and physical performance and any damage to this structure
tropocollagen
collagen fibrils
Figure 1. The assembly of collagen fibrils from tropocollagen molecules. Procollagen molecules are expressed within the cell and are modified via the cleavage of N
and C termini. The resulting molecules self assemble to form tropocollagen molecules, which are subsequently self-assembled into collagen fibrils. Fibrillar diameter
depends strongly on tissue type. (Online version in colour.)
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potentially resulting in long-term disability. In addition to
playing an important structural role, the organization of
these ECM components strongly influences cell behaviour,
offering cues that control cell differentiation, attachment,
recruitment, migration and further ECM production [4].
The interplay between the embedded cells and the ECM
itself means that tissues are able to constantly remodel in
response to changes in loading and oxygen levels so that
they are able to respond to the demands that are placed on
the body. This impressive ability to adapt also makes the
regeneration of tissues to their native states challenging.
Soft connective tissues contain high proportions of structural
fibrillar proteins such as collagen types I and II with modifi-
cations in structure that enable them to exhibit impressive
mechanical properties. Cartilage, for example, obtains its
shock-absorbing properties from high concentrations of hya-
luronan and proteoglycan aggrecans and the rigidity of bone
is a function of calcium phosphate present in the fibrillar col-
lagen matrix. Below, the principle roles of collagen, GAGs
and proteoglycans are introduced in more detail. It is noted
that other molecules within the ECM (elastin, laminin
and vitronection) have important mechanical and biological
functions, but these lay beyond the scope of this paper.(a) Collagen
Collagen is the most abundant protein that is found in the
human body [5]. There are, at present, 28 known collagen
types, which can be classified into fibril forming (I, II and
XI), fibril associated (IX, XII and XIV), transmembrane (XIII
and XVII), network forming (VI, VII and X), anchoring base-
ment membrane (IV) and a selection of others with highlyspecific functions. In ligaments and tendons, type I is the
most prevalent, constituting up to 90% of the total weight. Col-
lagen type I is a structural protein with a triple helical
conformation made up of two a1 chains and one a2 chain,
that offers load-bearing tissue sufficient mechanical strength
to withstand uniaxial and multiaxial loads [5]. The folding of
the triple helix is due to glycine (Gly—the smallest amino
acid) recurring in the Gly-X-Y amino acid sequence from
which collagen is formed. X and Y are most commonly the
amino acids proline and hydroxyproline, giving a repeating
motif of Gly-Pro-Hyp [6]. It is the close packing of the three
strands, hydrogen bonding and the high concentration of
amino acids proline and hydroxyproline that stabilizes the
triple helix [6]. The amino acids proline and 4-hydroxyproline
are also referred to as imino acids [6,7] as they have one hydro-
gen atom attached to the nitrogen atom and when this forms
part of an additional bond, there are no free hydrogen atoms
available for hydrogen bonding. As a result, the presence of
proline/hydroxyproline in the collagen molecule provides
the flexibility needed to maintain the helical conformation
for stability. When X and Y residues are not imino acids,
they allow collagen fibril formation through attachment to
other collagen molecules, integrins or ECM molecules [7,8].
Further stabilization of the collagen triple helix is achieved
through binding of individual helices (tropocollagens) into col-
lagen fibrils [9]. These fibrils can also join to form bundles and
cross-link for enhanced stability [9] (figure 1).(b) Glycosaminoglycans
Glycosaminoglycans (GAGs) are linear polysaccharide
chains, which are usually highly sulfated and negatively
charged [10]. Sulfated GAGs include chondroitin, dermatan
subchondral bone-type I collagen,
osteoblasts, osteocytes
non-mineralized fibrocartilage
types I and II collagen
ovoid chondrocytes
ligament mid- substance
types I and III collagen
fibroblast cells
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and hyaluronan are unsulfated [11]. GAGs have extensive
interaction with proteins such as growth factors, chemokines
and cytokines [12] and the GAG long chains shield the pro-
teins from proteolysis [13]. Connective tissues have high
quantities of hyaluronan (hyaluronic acid), which aids cell
migration and proliferation and maintains tissue hydra-
tion [14]. While the long chains are not very flexible, they
are highly soluble in water and assume conformations that
can trap large volumes of aqueous medium to form hydrated
gels, a property that gives connective tissues their resistance
to compressive stress [1].mineralized fibrocartilage (MFC)
types X collagen
hypertrophic chondrocytes
Figure 2. The heterogeneous structure of ligament tissue which prevents fail-
ure at the interface between bone and sinew. (Online version in colour.)
il.Trans.R.Soc.B
370:20140200(c) Proteoglycans
Proteoglycans are GAGs that are covalently bonded to a
protein and, as with GAGs, proteoglycans are important for
signal transduction and also provide additional structural
support to tissues [15]. Aggrecan, versican, neurocan and bre-
vican, collectively known as lecticans, are members of the
chondroitin sulfate proteoglycan family that offer resilience
to compressive force [16]. Other small proteoglycans whose
proteins have leucine-rich repeat structures (SLRPs), form
u-shaped structures suitable for protein–protein interactions
[17]. Members of the SLRP family are decorin, biglycan, fibro-
modulin, lumican and keratoca. Decorin is present in
connective tissue and, along with other SLRPs, contributes
to collagen fibril assembly and its regulation [17]. A study
by Matuszewski et al. [18] with the human supraspinatus
tendon, located in the shoulder, showed that aggregan and
biglycan distribution varied throughout the tendon with
the highest concentration being in the anterior and posterior
regions that experience the highest compressive stress
within this tissue and are prone to injury; decorin concen-
tration was high throughout the tendon as expected in
areas of high tensile strength. Proteoglycans that contain
heparan sulfate can bind with growth factors and other sig-
nalling molecules that can accelerate cell proliferation and
modulate behaviour [1].
The distribution of matrix components through tissues is
critical to mechanical performance. In the case of ligaments,
the ligament midsubstance consists of collagen type I fibrils,
which are aligned parallel to the principle axis of loading
(figure 2). Moving towards the extremities of a ligament,
there is a disruption in this order such that the collagenous
matrix becomes richer in proteoglycan and GAG molecules
with the formation of a homogeneous fibrocartilage structure.
Directly adjacent to the bone, there is a region of mineralized
fibrocartilage that directly abuts the subchondral bone. This
exquisite level of structural adaptation means that the sinew
is loaded almost purely in tension at its central portion and
the mineralized region is placed under compression. This
places each of the tissue components in a loading environment
in which they may perform optimally and minimizes the
chances of failure during locomotion [3]. It is this level of
ordering which also provides a significant challenge within
the field of regenerative medicine. It is, at present, impossible
to reproduce these properties in a synthetic material; there is
therefore a move towards using cells to create such structures
outside the body for subsequent implantation. In order to
understand how this may be done, it is important to under-
stand how cells may interact with and be influenced by
matrix components and other cells.3. Cell–matrix interactions
Cells that are found within the ECM are critical to long-term
adaptation and can therefore have an important role in the
process of regeneration, particularly, in tissue deposition
and restructuring. As the majority of human cells are ancho-
rage dependent, their ability to form an adhesion with the
ECM is critical to cell survival and behaviour [19]. The cell
membrane consists of a phospholipid bilayer engulfed by a
polysaccharide layer called the glycocalyx, which is ionizable
resulting in a net negative charge on the cell surface [1].
The polymeric materials used for culturing cells in vitro are
typically coated with poly-L-lysine, which has positively
charged amine groups [1,20]. As a consequence, non-specific
adhesion of various types of cells to solid surfaces occurs
through weakly attractive electrostatic van der Waals forces
[1]. The attachment of cells to the ECM is more specific and
occurs through the interaction of moieties on ECM molecules
with cell-surface glycoproteins known as integrins (figure 3).
Integrin molecules contain 1–18 a and 1–8 b subunits
arranged in different combinations. Many integrins bind to
the same ligands on ECM components that contain the
amino acid sequence Arg-Gly-Asp commonly known as
RGD [1,21]. Typical ECM components that have the RGD
sequence are vitronectin, bronectin and tenascin, though on
collagen and laminin these are more obscure [22].
Fibroblasts express integrins with subunit arrangement
a1b1 and a2b1 that bind to collagen simultaneously, however
a2b1 has been found to have a greater affinity for collagen
type I [23]. In three-dimensional collagen matrices, cells
deficient in a1b1 receptors showed decreased growth,
whereas presence of a2b1 enhanced the expression of
collagen-degrading enzymes MMP-1 and MMP-13 [23,24],
which mediates matrix renewal. The two integrins appear
to have different roles because during wound healing a2b1
expression is upregulated by fibroblasts while that of a1b1
is downregulated [23]. Endothelial cells proliferate during
wound healing and they possess aVb3 as their most promi-
nent integrin [24]. In addition, dermal endothelial cells
cultured in fibronectin or fibrin gels expressed higher
mRNA levels of aVb3 than when cultured in collagen gels.
As a result, aVb3 is an integrin implicated in cell–fibrin
integrin cell
membrane
glycoproteins
fibronectin
showing the
RGD motif
intracellular
components
actin filament from
the cytoskeleton
Figure 3. The interactions that occur between a cell adhesive fibrillar matrix bearing the RGD motif and an adhesion-dependent mammalian cell. The integrin subunits
mediate attachment of the matrix to the actin cytoskeleton and enable stress transfer that can initiate tissue remodelling. (Online version in colour.)
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gen though binding of aIIbb3 and aXb1 on fibrinogen motifs
Lys-Gln-Ala-Gly-Asp-Val (KQAGDV) and Gly-Pro-Arg-Pro
(GPRP), respectively [25].
The clustering of integrins between a cell membrane and
ECM molecules results in the formation of a focal adhesion
complex, which anchors a network of actin stress fibres within
the cell. This link between the cell and the ECM is what enables
the cells to experience themechanical loading applied to the cell
population and critically activates pathways that enable the
digestion of matrix and the concomitant deposition of new
ECM. An improved understanding of the processes that occur
during cell adhesion and how such processes govern tissue for-
mation has opened the possibility of creating tissues in vitro.
This may be achieved by placing the cell population in an
environment that can stimulate the attached cells to secrete
new ECM. Given the reported differences in cell behaviour
when cultured in a three-dimensional structure as compared
with in amonolayer system,muchwork has recently been dedi-
cated to understanding the fundamental differences in
behaviour between cell populations that are cultured in two
and three dimensions. There is a now a general consensus thatreproducing the complex tissue architectures that are found in
vivo requires the provision of a three-dimensional support that
provides cues to stimulate the embedded cell population to
develop new matrix. The remainder of the paper will detail
how three-dimensional culture in biologically derived matrices
may enable the formation of organized tissue structures.4. Tissue production in vitro exploiting cell–
matrix interactions
One way to encourage cells to secrete their own matrix and
digest that to which they are attached is through the use of
a temporary matrix to support the cells during growth. A
matrix that has been shown to enable this is fibrin which
facilitates cell attachment through an integrin matrix and
may be readily reorganized by seeded cells. It is readily avail-
able through the collection of a small blood sample and fulfils
an important haemostatic role during the process of wound
healing in the body, providing a matrix onto which cells
can attach and eventually be replaced by native tissue. It is
formed from the cleavage of fibrinogen by thrombin, which
(a)
(b)
(d )
(c) (e)
T
T
An
0 100mm
0 250mm
Figure 4. Free floating (a) and attached (b) fibrin-gel cultures seeded with fibroblasts after three weeks in culture (scale bars, 10 mm). (c) By 15 days of culture,
cells in the central portion (stained with DAPI and phalloidin) were elongated and were orientated along the long axis of the sinew structure (scale bar, 100 mm).
(d,e) Close examination of the interface with the ceramic brackets showed that levels of orientation varied from the ligament midsubstance (labelled T) to the
interface with the anchor (labelled An). Scale bar, 8 mm in (d), 250 mm in (e). (Online version in colour.)
(a) (c)
(b)
200 mm
200 mm 5 nm
10 mm
(d )
Figure 5. Imaging of ECM in the engineered tissues. Haematoxylin and eosin
staining demonstrated the extent of cell and matrix alignment within the
structure (a,b) and the enhanced density of the sinews following treatment
with anabolic agents (b). Transmission electron microscopy demonstrated the
presence of aligned fibrillar structures along the long axis of the sinew on the
micro- (c) and nano-scales (d ). (Online version in colour.)
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affinity of what are known as knobs A and B, which fit into
holes a and b and result in gelation through the formation
of protofibrils, which eventually self assemble to form a fibril-
lar network [26–28]. Fibroblasts seeded into a fibrin gel on
the surface of a culture dish then associate with the fibrillar
structure and will begin to contract the matrix and eventually
a sphere of gelatinous material will be formed within the cul-
ture dish (figure 4a). By retaining the fibrin gel in the dish by
using pins and sutures [29,30] or a calcium-phosphate cer-
amic with an inherently tissue-adhesive nature (figure 4b)
[31,32], a gel cylinder is formed between the points ofretention. The retention of the sinew-like structure by the cer-
amic brackets results in a passive tension between the
ceramics [33] and this forces cell and molecular alignment
[34] within the newly formed matrix (figure 4c–f ). The cells
have elongated cell bodies and nuclei suggestive of a tenocy-
tic phenotype [35]. Interestingly, the level of orientation is
significantly lower at the interface with the calcium phos-
phate ceramic suggestive of the development of a structure
with multiple levels of organization (figure 4e).
After short periods of culture, the sinews typically consist
of very small quantities of collagen (less than 5 wt%) [29,30].
However, it has been shown that it is possible to accelerate
type I collagen deposition within the sinew by chemical treat-
ment with ascorbic acid and proline [31], the former of which
is involved in processing the procollagen molecules and the
latter is added to prevent substrate limitation of collagen I
production. Others have also demonstrated that it is possible
to enhance collagen production through the application of a
cocktail of growth factors [36]. It has also been demonstrated
that intermittent bouts of cyclic mechanical conditioning of
the sinew model results in an enhancement of collagen depo-
sition and the mechanical strength of the resulting structures,
although care must be taken to prevent matrix damage that
can occur as a consequence of the application of more than
5% strain [37]. Recent unpublished results from our group
have shown that it is possible to generate sinews with as
high as 50 wt% of collagen I by also optimizing the mechan-
ical properties of the supporting fibrin gel. Our hypothesis
for this phenomenon is that an increase in local modulus
enhances the mechanical stimulus provided to the cell popu-
lation and upregulates collagen through the ERK pathway.
Histological analysis demonstrated that the sinew itself had
a highly orientated ECM (figure 5a) with the use of the col-
lagen promotors ascorbic acid (AA) and proline (P) causing
an enhancement in the density of the matrix (figure 5b).
Examination of the ultrastructure using transmission electron
microscopy (TEM) demonstrated the alignment of fibrils at
the micro (figure 5c) and nano scales (figure 5d ).
day 0
day 17 day 17
cells bridging
the gap
between
braids
Figure 6. Macrostructral organization of the engineered sinews demonstrating the amalgamation of the individual strands over a period of 17 days in culture.
(Online version in colour.)
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Ligaments and tendons are formed from multiple fascicles
that interact with one another. The interactions that form
between individual fascicles have been proposed to be res-
ponsible for enhancing the mechanical properties exhibited
by native ligaments and tendon. The fascicles themselves are
bundled together and surrounded by a membranous struc-
ture known as the epitenon [38]. In order to replicate this
arrangement, it is possible to culture individual sinews in
close proximity over a period of weeks. In the course of this
time, the individual strands grow together and eventually
amalgamate. The amalgamation is as a consequence of cellular
bridging between the structures in addition to the formation
of ECM between the individual strands (figure 6). Importan-
tly, this kind of macrostructural organization of the sinew-
like structures results in mechanical augmentation of the
structure and deformation behaviour similar to that observed
for native sinews.6. Conclusion and future directions
By controlling how cells are able to manipulate a soft matrix
in vitro it is possible to generate a heterogeneously structured
material with structure and deformation characteristics that
resemble those of native ligaments and tendons. The mechan-
ical properties that are exhibited by these structures are
orders of magnitude lower than those exhibited by native
ligaments and tendons and so it is unlikely that they will
replace current methods for ligament and tendon reconstruc-
tion in the very near future. Current directions of research are
seeking to use this structured material as a means to augment
healing in the body. We have recently published a method for
decellularizing these structures [39] so that they may be manu-
factured and stored prior to implantation into patients to
enhance the success of currently existing methods of tissue
reconstruction. The aligned collagenous matrix is also being
used as a model for diseases where mineral deposition within
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